Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2015

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • 1 Offline
    1 Offline
    120281
    wrote on sidst redigeret af
    #319

    Eller de tænker de heller vil byde 1000kr for Genmab. Så få Genmab inden godkendelse.

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #320

      Jeg mener det er en vanvittig pris

      1 Reply Last reply
      0
      • 1 Offline
        1 Offline
        120281
        wrote on sidst redigeret af
        #321

        Ja pcyc er one trick pony

        1 Reply Last reply
        0
        • 1 Offline
          1 Offline
          120281
          wrote on sidst redigeret af
          #322

          Mener top salg er 3,5 mia USD i 2020. Mindre end daras 5 mia USD. Samt gen har arzerra. Men pct har jo deres produkt på markedet. Det har Genmab ikke, og der den store forskel ligger.

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #323

            Netop derfor !

            1 Reply Last reply
            0
            • MadsSkjernM Offline
              MadsSkjernM Offline
              MadsSkjern
              wrote on sidst redigeret af
              #324

              En anden nyhed fra USA igår var godkendelse af Opdivo i NSCLC (en form for lungekræft) FDA godkendte ansøgningen 5dage (!) efter accept af ansøgning. Det kan pludsligt gå stærkt for Dara...

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #325

                Synes jeg har læst 3,6 bn i 2018. Men alligevel kun 50% til PCYC - der er en lang tilbagebetalingstid og hele tiden udvikles stoffer og det går af patent om vel 10 år

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #326

                  Havde den BTD

                  1 Reply Last reply
                  0
                  • MadsSkjernM Offline
                    MadsSkjernM Offline
                    MadsSkjern
                    wrote on sidst redigeret af
                    #327

                    Ja. Godkendt i Malign Melanom i dec14. Resultater i NSCLC i jan15 og nu godkendt i den indikation også

                    1 Reply Last reply
                    0
                    • MadsSkjernM Offline
                      MadsSkjernM Offline
                      MadsSkjern
                      wrote on sidst redigeret af
                      #328

                      Det går pænt stærkt

                      1 Reply Last reply
                      0
                      • MadsSkjernM Offline
                        MadsSkjernM Offline
                        MadsSkjern
                        wrote on sidst redigeret af
                        #329

                        Link Preview Image
                        U.S. FDA approves Bristol-Myers immunotherapy for lung cancer

                        U.S. health regulators on Wednesday swiftly approved a Bristol-Myers Squibb Co drug that helps the immune system fight the most common form of lung cancer, sending the company's shares up more than 5 percent to a multi-year high. The eagerly anticipated Food and Drug Administration approval of the drug known as Opdivo came only about three months after Bristol provided trial results showing that the medicine extended survival in non-small cell lung cancer (NSCLC), one of the biggest markets in oncology. "This approval will provide patients and health care providers knowledge of the survival advantage associated with Opdivo and will help guide patient care and future lung cancer trials," Richard Pazdur, the FDA's head of hematology and oncology product evaluation, said in a statement. Opdivo, known chemically as nivolumab, was approved to treat non-small cell lung cancer after the disease has progressed following platinum-based chemotherapy, typically the first-line treatment against the disease.

                        favicon

                        Yahoo Finance (finance.yahoo.com)

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #330

                          Vær opmærksom på, at det er udvidelse af label og ikke et nyt stof for FDA

                          1 Reply Last reply
                          0
                          • investor1989I Offline
                            investor1989I Offline
                            investor1989
                            wrote on sidst redigeret af
                            #331

                            Bare til de af jer der godt kan lide pinsler. Mener jeg solgte mine PCYC omkring kurs 125 $

                            1 Reply Last reply
                            0
                            • MadsSkjernM Offline
                              MadsSkjernM Offline
                              MadsSkjern
                              wrote on sidst redigeret af
                              #332

                              Det er rigtigt Solsen, men det viser at FDA kan flytte sig hurtigt, når det er et stof de ser muligheder i.

                              1 Reply Last reply
                              0
                              • celsiusC Offline
                                celsiusC Offline
                                celsius
                                wrote on sidst redigeret af
                                #333

                                ved godt det ender sådan men alligevel ..der ligger 25 stk.
                                bud på 550 her til morgen på nordea invest -:)

                                1 Reply Last reply
                                0
                                • MadsSkjernM Offline
                                  MadsSkjernM Offline
                                  MadsSkjern
                                  wrote on sidst redigeret af
                                  #334

                                  Lige min tanke Helge. Fem dage er vel den tid det tager at stemple papirerne 🐵

                                  1 Reply Last reply
                                  0
                                  • investor1989I Offline
                                    investor1989I Offline
                                    investor1989
                                    wrote on sidst redigeret af
                                    #335

                                    530 ligner det i åbningen 🙂

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #336

                                      🙂 Markedet sover ikke

                                      1 Reply Last reply
                                      0
                                      • investor1989I Offline
                                        investor1989I Offline
                                        investor1989
                                        wrote on sidst redigeret af
                                        #337

                                        Nej når PCYC sælges til 21 mia. $ skal Genmab ikke koste 3 mia. $ 🙂

                                        1 Reply Last reply
                                        0
                                        • investor1989I Offline
                                          investor1989I Offline
                                          investor1989
                                          wrote on sidst redigeret af
                                          #338

                                          Daratumumab er jo den næste Ibrutinib. Det er bare 2-3 år efter

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger